Variable sensitivity to bacterial methionyl-tRNA synthetase inhibitors reveals subpopulations of Streptococcus pneumoniae with two distinct methionyl-tRNA synthetase genes
- PMID: 12760849
- PMCID: PMC155832
- DOI: 10.1128/AAC.47.6.1784-1789.2003
Variable sensitivity to bacterial methionyl-tRNA synthetase inhibitors reveals subpopulations of Streptococcus pneumoniae with two distinct methionyl-tRNA synthetase genes
Abstract
As reported previously (J. R. Jarvest et al., J. Med. Chem. 45:1952-1962, 2002), potent inhibitors (at nanomolar concentrations) of Staphylococcus aureus methionyl-tRNA synthetase (MetS; encoded by metS1) have been derived from a high-throughput screening assay hit. Optimized compounds showed excellent activities against staphylococcal and enterococcal pathogens. We report on the bimodal susceptibilities of S. pneumoniae strains, a significant fraction of which was found to be resistant (MIC, > or =8 mg/liter) to these inhibitors. Using molecular genetic techniques, we have found that the mechanism of resistance is the presence of a second, distantly related MetS enzyme, MetS2, encoded by metS2. We present evidence that the metS2 gene is necessary and sufficient for resistance to MetS inhibitors. PCR analysis for the presence of metS2 among a large sample (n = 315) of S. pneumoniae isolates revealed that it is widespread geographically and chronologically, occurring at a frequency of about 46%. All isolates tested also contained the metS1 gene. Searches of public sequence databases revealed that S. pneumoniae MetS2 was most similar to MetS in Bacillus anthracis, followed by MetS in various non-gram-positive bacterial, archaeal, and eukaryotic species, with streptococcal MetS being considerably less similar. We propose that the presence of metS2 in specific strains of S. pneumoniae is the result of horizontal gene transfer which has been driven by selection for resistance to some unknown class of naturally occurring antibiotics with similarities to recently reported synthetic MetS inhibitors.
Figures
Similar articles
-
Novel methionyl-tRNA synthetase gene variants/phenotypes in interstitial lung and liver disease: A case report and review of literature.World J Gastroenterol. 2018 Sep 28;24(36):4208-4216. doi: 10.3748/wjg.v24.i36.4208. World J Gastroenterol. 2018. PMID: 30271085 Free PMC article. Review.
-
Recent advances in the preclinical evaluation of the topical antibacterial agent REP8839.Curr Opin Chem Biol. 2008 Aug;12(4):409-17. doi: 10.1016/j.cbpa.2008.06.011. Epub 2008 Jul 11. Curr Opin Chem Biol. 2008. PMID: 18620074 Review.
-
Evaluation of the metS and murB loci for antibiotic discovery using targeted antisense RNA expression analysis in Bacillus anthracis.Antimicrob Agents Chemother. 2007 May;51(5):1708-18. doi: 10.1128/AAC.01180-06. Epub 2007 Mar 5. Antimicrob Agents Chemother. 2007. PMID: 17339372 Free PMC article.
-
Mode of action and biochemical characterization of REP8839, a novel inhibitor of methionyl-tRNA synthetase.Antimicrob Agents Chemother. 2005 Oct;49(10):4253-62. doi: 10.1128/AAC.49.10.4253-4262.2005. Antimicrob Agents Chemother. 2005. PMID: 16189106 Free PMC article.
-
Horizontal transfer of drug-resistant aminoacyl-transfer-RNA synthetases of anthrax and Gram-positive pathogens.EMBO Rep. 2003 Jul;4(7):692-8. doi: 10.1038/sj.embor.embor881. EMBO Rep. 2003. PMID: 12792655 Free PMC article.
Cited by
-
A Systematic Strategy to Find Potential Therapeutic Targets for Pseudomonas aeruginosa Using Integrated Computational Models.Front Mol Biosci. 2021 Sep 20;8:728129. doi: 10.3389/fmolb.2021.728129. eCollection 2021. Front Mol Biosci. 2021. PMID: 34616771 Free PMC article.
-
Molecular basis for diaryldiamine selectivity and competition with tRNA in a type 2 methionyl-tRNA synthetase from a Gram-negative bacterium.J Biol Chem. 2021 Jan-Jun;296:100658. doi: 10.1016/j.jbc.2021.100658. Epub 2021 Apr 12. J Biol Chem. 2021. PMID: 33857480 Free PMC article.
-
Spontaneous Selection of Cryptosporidium Drug Resistance in a Calf Model of Infection.Antimicrob Agents Chemother. 2021 May 18;65(6):e00023-21. doi: 10.1128/AAC.00023-21. Print 2021 May 18. Antimicrob Agents Chemother. 2021. PMID: 33753338 Free PMC article.
-
Aminoacyl-tRNA Synthetases as Valuable Targets for Antimicrobial Drug Discovery.Int J Mol Sci. 2021 Feb 10;22(4):1750. doi: 10.3390/ijms22041750. Int J Mol Sci. 2021. PMID: 33578647 Free PMC article. Review.
-
Structure-guided discovery of selective methionyl-tRNA synthetase inhibitors with potent activity against Trypanosoma brucei.RSC Med Chem. 2020 May 18;11(8):885-895. doi: 10.1039/d0md00057d. eCollection 2020 Aug 1. RSC Med Chem. 2020. PMID: 33479683 Free PMC article.
References
-
- Brown, J. R. 1998. Aminoacyl-tRNA synthetases. Evolution of a troubled family, p. 217-230. In J. Wiegel and M. W. W. Adams (ed.), Thermophiles: the keys to molecular evolution and the origin of life? Taylor and Francis Ltd., London, United Kingdom.
-
- Brown, J. R., J. Zhang, and J. E. Hodgson. 1998. A bacterial antibiotic resistance gene with eukaryotic origins. Curr. Biol. 8:R365-R367. - PubMed
-
- Dyke, K. G. H., S. P. Curnock, M. Golding, and W. C. Noble. 1991. Cloning of the gene conferring resistance to mupirocin in Staphylococcus aureus. FEMS Microbiol. Lett. 77:195-198. - PubMed
-
- Felmingham, D., and J. Washington. 1999. Trends in the antimicrobial susceptibility of bacterial respiratory tract pathogens—findings of the Alexander Project 1992-1996. J. Chemother. 11:5-21. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous